Should I have that blood test for Prostate Cancer?

Slides:



Advertisements
Similar presentations
Fight Back Against Cancer: Screening and Early Detection
Advertisements

Breast Cancer Early Detection is Your Best Protection
The Role of Urine cytology in the investigation of Haematuria? B Barrass Audit Meeting 17 th May 2006.
Screening for Prostate Cancer: Sharing the Decision 7/1/03.
Prostate Cancer Genetics and Diagnosis
Prevention Strategies Rajesh G. Laungani MD Director, Robotic Urology Chairman, Prostate Cancer Center Saint Joseph’s Hospital, Atlanta.
Prostate Cancer One of the commonest causes of death in the Western World USA 2005 – 232,090 new cases – 30,350 deaths Lifetime risk of disease 16.6% Lifetime.
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Breast Cancer Awareness October is Breast Cancer Awareness Month Submitted by Kadee Brousseau, Peer Advisor, University of Missouri.
A PRACTICAL GUIDE TO PSA SCREENING Kendall Itoku, MD St. Louis Urological Surgeons.
Mr Jonathan Lewin MBBS, MRCS, MD, FRCS(Urol), FRACS Consultant Uro-Oncological Surgeon.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
EVIDENCE AND DEBATE SCREENING FOR PROSTATE CANCER.
PSA & Prostate Cancer Dan Burke Consultant Urological Surgeon
Prostate Cancer Education Seminar. What is the Prostate? A male sex gland The size of a walnut below the bladder and in front of the rectum Produces the.
Prostate Cancer: Education & Outreach Center for Cancer Prevention & Control Prevention and Health Promotion Administration Maryland Department of Health.
Prostate Cancer: Education & Outreach
Screening PHIL THIRKELL. What is screening?  A process of identifying apparently healthy people who may be at risk of a disease or condition  Identify.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
Lecture Fourteen Biomedical Engineering for Global Health.
Mr Jim Adshead MA MD FRCS (Urol) Consultant Urological Surgeon Lister Hospital, Stevenage Spire Hospital Harpenden E mail:
Eleni Galani Medical Oncologist
Early Detection Is Your Best Protection. Breast Cancer Statistics for Women A woman has a one in eight chance of developing breast cancer in her lifetime.
Professor Abhay Rane OBE
Towards Earlier Cancer Diagnosis Hamish Whitaker GP Tutor Guildford.
Clare Rogers Consultant Breast Surgeon Doncaster and Bassetlaw Hospitals.
Prostate Screening in 2009: New Findings and New Questions Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer.
Prostate Cancer Screening. Google Search “Prostate Cancer” “Google Health” prostate cancer (OK) “Should All Men Be Screened for Prostate Cancer?” ABC.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
A/Prof Brian Cox Cancer Epidemiologist Dunedin. Research Associate Professor Brian Cox Hugh Adam Cancer Epidemiology Unit Department of Preventive and.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
Urology Update Sanofi- Aventis
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.
All about PSA (not Pharmaceutical Society of Australia)
“The African American Prostate Cancer Crisis in Numbers”
PCa Screening New Areas of Research Francesco Montorsi Milan.
“I am a prostate cancer survivor and I am very thankful that the Men’s Health Clinic was started here on Standing Rock.” Del Lecompte, Fort Yates,
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
PSA Testing Importance of Multiple Markers Ian Thompson MD Department of Urology University of Texas HSC San Antonio, TX.
Men’s Health Prostate Awareness. Prostate Where is it? Where is it? What is a prostate? What is a prostate? What’s the issue? What’s the issue?
Prostate Cancer Screening Risk Management Ben Inch.
1 Ambassador Program Presentation Prevention & Early Detection PROSTATE CANCER.
Prostate Screening in the New Millennium Dr Pamela Ajayi MD PathCare.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Colonic cancer screening in high risk groups
Prostate Cancer. What is the Prostate Gland What is the prostate Gland Size of a chestnut Just beneath the bladder Urethra runs through its middle Its.
PSA - Prostate Specific Antigen Bill Graden, M.D. BYU Student Health Center.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
Prostate Cancer Awareness In association with. What is Prostate Cancer?
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
Prostate cancer and ethnicity Luke Hounsome Public Health England ‘Hear me now’ workshop - Birmingham.
PSA Consensus and The Prostate Cancer Risk Management Programme Karen Stalbow, Prostate Cancer UK Dr Ali Cooper, Prostate Cancer UK Annual Conference 2016.
Screening for Prostate Cancer
Chris Stubbings Uro-oncology CNS
Screening for Ovarian Cancer
Cancer Screening: Who, When and Why?
A Few Facts About Breast Cancer
Definition of Cancer Screening
Cancer screening PROF .MAZIN AL-HAWAZ.
BME 301 Lecture Fourteen.
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
PSA testing.
Prostate Cancer Update
Does PSA Testing Influence the Natural History of Prostate Cancer?
Prostate cancer screening beyond PSA – STHLM3 and/or MRI
Presentation transcript:

Should I have that blood test for Prostate Cancer?

PSA screening Understand what the PSA test is Identify when it should be used Describe the pros and cons of PSA testing

Prostate Cancer Commonest cause of cancer in men in the UK 2 nd commonest cause of cancer death in men in the UK Average age of diagnosis is 70 – 74 yrs of age Much less common under 50 yrs of age Average age of mortality is 80 – 84 yrs of age 1 in 26 men in the UK will die from Prostate Cancer

Risk Factors for Prostate Cancer Age (strongest risk factor) Family history – especially if relative diagnosed before age of 55 yrs –Also link to BRCA 1 and 2 so consider FHx breast cancer relative Black men > 3 times more likely than white men (oriental/asian men lowest risk) Diet inconclusive

What is the PSA? A Glyccoprotein which liquefies semen and aids sperm motility

PSA Testing ANY man aged over 50 who requests a PSA after careful consideration should be tested Expressed in benign and malignant conditions Test benefits –Diagnose cancer before symptoms –Diagnose at a stage where could be cured or life extended –Serial measurements may help in diagnosis Test limitations –PSA not diagnostic or tumour specific –False reassurance: 15% of men with a normal PSA will have Prostate Cancer and 2-3% will have high grade Prostate Cancer –Identification of cancers which may not become clinically evident in the patient’s lifetime

Stats Sensitivity (rules diagnosis in) –21 % for all prostate cancers –51 % for high grade prostate cancers –Using a PSA cut off of 4.0 Specificity (rules diagnosis out) –91 % for all prostate cancers –Using a PSA cut off of 4.0 Positive Predictive Value (proportion of men with an elevated PSA who have Prostate Cancer) –30 % for a PSA level of > 4.0 –Less than 1 in 3 men with a PSA of > 4.0 will have Prostate Cancer detected on biopsy

Conditions for PSA testing One should not check the PSA (has a half life of 2.2 days) –During an active UTI –If ejaculated within previous 48 hrs (rise of up to 0.8) –If exercised vigourously within previous 48 hrs –Had a DRE within 1 week (although some studies suggest minimal rise 0.26 –0.4) –Had a Prostate Biopsy within 1 week (rise of 7.9) –Nb 5 Alpha Reductase inihibitors may reduce PSA by 50% within 6 months DRE is useful for men with LUTS but not for asymptommatic men

Referrals If PSA raised above age specific limit –Refer Urology 2WW

Questions?